TR
EN
The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration
Abstract
Aim: The endoplasmic reticulum (ER) chaperone BiP is a central node in the unfolded protein response and a key therapeutic target in diseases driven by ER stress, such as cancer and neurodegeneration. However, therapeutic development is hampered by an incomplete understanding of the conformational dynamics that govern its substrate binding and release cycle.
Materials and Methods: We performed a 100-nanosecond all-atomic molecular dynamics simulation of human BiP (PDB: 5e84) to characterize the flexibility of its substrate binding domain alpha (SBDα). We analyzed RMSD, inter-domain distances, and the free energy landscape to map its conformational states.
Results: Our simulations revealed that BiP exists in two distinct, low-energy conformational states: a predominant "extended" state (90% occupancy) and a transient "bent" state. The SBDα undergoes a rapid bending-restoring motion, with distances between key domains collapsing from ~25 Å to 3 Å within a 10 ns timescale. This motion represents a molecular switch with a moderate energy barrier of 25-30 kJ/mol, making it accessible at physiological temperatures.
Conclusions: The identified two-state conformational switch is a functionally critical feature that explains BiP's dynamic substrate handling. This molecular motion represents a "druggable" mechanism. Stabilizing either the extended or bent state with small molecules offers a tangible therapeutic strategy for modulating BiP activity, such as inhibiting its pro-survival function in cancer or enhancing its protective role in neurodegeneration.
Keywords
Ethical Statement
This study did not involve human subjects, animal experiments, or other ethical considerations requiring institutional review board approval.
Thanks
This study was derived from the PhD thesis of Zekeriya Düzgün. The numerical calculations reported in this paper were partially performed at TUBITAK ULAKBIM, High Performance, and Grid Computing Center (TRUBA resources). Declaration of generative AI and AI-assisted technologies: During the preparation of this work, the author(s) used Anthropic Claude 4.0 and Google Gemini 2.5 pro in order to assist with language editing, grammar correction, manuscript formatting. After using these tools/services, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.
References
- Fernández L, Kong CS, Alkhoury M, Tryfonos M, Brighton PJ, et al. The endoplasmic reticulum protein HSPA5/BiP is essential for decidual transformation of human endometrial stromal cells. Sci Rep. 2024;14(1).
- Li T, Fu J, Cheng J, Elfiky AA, Wei C, et al. New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19. Front Immunol. 2023;14:1166680.
- Chen X, Shi C, He M, Xiong S, Xia X. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther. 2023;8(1):352.
- Obaseki I, Ndolo CC, Adedeji AA, Popoola HO, Kravats AN. The structural and functional dynamics of BiP and Grp94: opportunities for therapeutic discovery. Trends Pharmacol Sci. 2025;46(5):453–67.
- Hendershot LM, Buck TM, Brodsky JL. The Essential Functions of Molecular Chaperones and Folding Enzymes in Maintaining Endoplasmic Reticulum Homeostasis. J Mol Biol. 2024;436(14).
- Yang J, Nune M, Zong Y, Zhou L, Liu Q. Close and Allosteric Opening of the Polypeptide-Binding Site in a Human Hsp70 Chaperone BiP. Structure. 2015;23(12):2191–203.
- Brown BP, Stein RA, Meiler J, Mchaourab HS. Approximating Projections of Conformational Boltzmann Distributions with AlphaFold2 Predictions: Opportunities and Limitations. J Chem Theory Comput. 2024;20(3):1434–47.
- Meersche Y Vander, Cretin G, Gheeraert A, Gelly JC, Galochkina T. ATLAS: protein flexibility description from atomistic molecular dynamics simulations. Nucleic Acids Res. 2024;52(D1):D384–92.
Details
Primary Language
English
Subjects
Medical Molecular Engineering of Nucleic Acids and Proteins
Journal Section
Research Article
Publication Date
March 9, 2026
Submission Date
July 24, 2025
Acceptance Date
September 12, 2025
Published in Issue
Year 2026 Volume: 65 Number: 1
APA
Düzgün, Z., & Eroğlu, Z. (2026). The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. Ege Tıp Dergisi, 65(1), 11-17. https://doi.org/10.19161/etd.1750148
AMA
1.Düzgün Z, Eroğlu Z. The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. EJM. 2026;65(1):11-17. doi:10.19161/etd.1750148
Chicago
Düzgün, Zekeriya, and Zuhal Eroğlu. 2026. “The Two-State Switch of Chaperone BIP: A Druggable Target for Endoplasmic Reticulum Stress in Cancer and Neurodegeneration”. Ege Tıp Dergisi 65 (1): 11-17. https://doi.org/10.19161/etd.1750148.
EndNote
Düzgün Z, Eroğlu Z (March 1, 2026) The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. Ege Tıp Dergisi 65 1 11–17.
IEEE
[1]Z. Düzgün and Z. Eroğlu, “The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration”, EJM, vol. 65, no. 1, pp. 11–17, Mar. 2026, doi: 10.19161/etd.1750148.
ISNAD
Düzgün, Zekeriya - Eroğlu, Zuhal. “The Two-State Switch of Chaperone BIP: A Druggable Target for Endoplasmic Reticulum Stress in Cancer and Neurodegeneration”. Ege Tıp Dergisi 65/1 (March 1, 2026): 11-17. https://doi.org/10.19161/etd.1750148.
JAMA
1.Düzgün Z, Eroğlu Z. The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. EJM. 2026;65:11–17.
MLA
Düzgün, Zekeriya, and Zuhal Eroğlu. “The Two-State Switch of Chaperone BIP: A Druggable Target for Endoplasmic Reticulum Stress in Cancer and Neurodegeneration”. Ege Tıp Dergisi, vol. 65, no. 1, Mar. 2026, pp. 11-17, doi:10.19161/etd.1750148.
Vancouver
1.Zekeriya Düzgün, Zuhal Eroğlu. The two-state switch of chaperone BIP: A druggable target for endoplasmic reticulum stress in cancer and neurodegeneration. EJM. 2026 Mar. 1;65(1):11-7. doi:10.19161/etd.1750148